GlassScriptPhysician profile
Robert J Clement Jr
NPI 1487645396
$14,722.84
in general payments reported to CMS, 2019-2025
42 companies · $1,018 in 2025
The $1,018 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,833 · 2020: $1,801 · 2021: $1,989 · 2022: $2,475 · 2023: $1,813 · 2024: $1,794 · 2025: $1,018.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,603 · Education: $20.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,603.20 |
| Education | $20.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,177.31 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $2,003.89 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $1,263.60 | 2020-2025 | Vraylar, Qulipta, Ubrelvy |
| Lilly USA, LLC | $1,158.23 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $917.68 | 2019-2025 | |
| Glaxosmithkline, LLC. | $906.02 | 2019-2025 | Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $878.94 | 2019-2022 | |
| Amgen INC. | $776.46 | 2019-2024 | Evenity, Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $704.80 | 2019-2025 | Jardiance, Synjardy |
| Merck Sharp & Dohme LLC | $611.88 | 2019-2023 | Belsomra, Januvia, Steglujan |
| Sanofi-Aventis U.S. LLC | $443.52 | 2019-2023 | |
| Exact Sciences Corporation | $348.32 | 2023-2025 | Cologuard Collection Kit |
| Allergan, INC. | $348.23 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $309.78 | 2019-2023 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $292.81 | 2019-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Clement Jr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.